Amit Lahoti is an expert in the field of Nephrology. He attended University of Texas Medical School. Doctor Amit Lahoti, MD is also a published MD. He has 13 paper published. The most recent paper is: Clinical Safety and Efficacy of Nilotinib or Dasatinib in Patients With Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia and Pre-Existing Liver and/or Renal ... He accepts all Medicare patients.
University of Texas Health Science Center
University of Texas Medical School
University of Texas M.D. Anderson Cancer Center
|
Dr. Julie Robeson, MD |
|
Dr. Venkataraman Ramanathan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Juan C. Ayus, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Shatishkumar Y. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kim Horn, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Advayanand G. Shirsalkar, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Chun Xie, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sai Kaumudi Saridey, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Abdulla K. Salahudeen, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Rohit R. Arora, MB BS |